Find a Tender
complete
Official procurement procedure
NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Framework Agreement for the supply of Inhalation Anaesthetics and Vaporisers". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The NHS Commissioning Board (operating under the name of NHS England) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
46Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England) | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published15 Mar 2021, 10:33 GMT | Last source update15 Mar 2021, 10:33 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-029b8b | ||
What is being bought
All Regions - 15 February 2021 to31 January 2023 (23.5 months)23.5 months with an option oroptions to extend (at the discretionof the Authority) for a period orperiods up to a total of 47 months
What changed
From the official release history
- Status changed to complete
15 Mar 2021, 10:33 GMT - Official notice release published
15 Mar 2021, 10:33 GMT - Buyer information updated
15 Mar 2021, 10:33 GMT
Lots and requirements (4)
Published by the contracting authority
- Lot 1 · #1Lot 1 - Supply of Sevoflurane Only - All RegionscancelledPublished valueNot publishedNHS National Generic Pharmaceuticals for the supply of InhalationAnaesthetics and VaporisersOffer reference number: CM/PHG/20/5626Period of framework agreement: 23.5 months with an option or options toextend (at the Authority’s discretion) for a period or periods up to a total of23.5 months. The total maximum duration of the framework agreement tobe no more than 47 monthsPotential periods of call-offs under the framework agreement:All Regions - 15 February 2021 to 31 January 2023 (23.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in theprocurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Lot 2 - Supply of Sevoflurane to include Vaporisers on loan - All RegionscancelledPublished valueNot publishedNHS National Generic Pharmaceuticals for the supply of InhalationAnaesthetics and VaporisersOffer reference number: CM/PHG/20/5626Period of framework agreement: 23.5 months with an option or options toextend (at the Authority’s discretion) for a period or periods up to a total of23.5 months. The total maximum duration of the framework agreement tobe no more than 47 monthsPotential periods of call-offs under the framework agreement: All Regions -15 February 2021 to 31 January 2023 (23.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in theprocurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Lot 3 - Supply of Desflurane Only - All RegionscancelledPublished valueNot publishedNHS National Generic Pharmaceuticals for the supply of InhalationAnaesthetics and VaporisersOffer reference number: CM/PHG/20/5626Period of framework agreement: 23.5 months with an option or options toextend (at the Authority’s discretion) for a period or periods up to a total of23.5 months. The total maximum duration of the framework agreement tobe no more than 47 monthsPotential periods of call-offs under the framework agreement: All Regions -15 February 2021 to 31 January 2023 (23.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in theprocurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4Lot 4 - Supply of Desflurane to include Vaporisers on loan - All RegionscancelledPublished valueNot publishedNHS National Generic Pharmaceuticals for the supply of InhalationAnaesthetics and VaporisersOffer reference number: CM/PHG/20/5626Period of framework agreement: 23.5 months with an option or options toextend (at the Authority’s discretion) for a period or periods up to a total of23.5 months. The total maximum duration of the framework agreement tobe no more than 47 monthsPotential periods of call-offs under the framework agreement: All Regions -15 February 2021 to 31 January 2023 (23.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in theprocurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
15 Mar 2021, 10:33 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1 - Contract active
Signed 9 Feb 2021, 00:00 GMT · £1
Commercial outcome and competition
Awards Abbvie Ltd Not published · Not published · active Kensington Pharma Ltd Not published · Not published · active Abbvie Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Abbvie Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Kensington Pharma Ltd Not published · Not published · active Piramal Critical care Limited Not published · Not published · active Piramal Critical care Limited Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Kensington Pharma Ltd Not published · Not published · active Baxter Healthcare Ltd Not published · Not published · active Kensington Pharma Ltd Not published · Not published · active Piramal Critical care Limited Not published · Not published · active Abbvie Ltd Not published · Not published · active Piramal Critical care Limited Not published · Not published · active |
Contracts Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active Contract £1 · signed 9 Feb 2021, 00:00 GMT · active |
Bid statistics bids: 4 (lot 1) bids: 4 (lot 1) bids: 4 (lot 1) bids: 4 (lot 1) electronicBids: 4 (lot 1) electronicBids: 4 (lot 1) electronicBids: 4 (lot 1) electronicBids: 4 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) foreignBidsFromNonEU: 0 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) smeBids: 2 (lot 1) bids: 4 (lot 2) bids: 4 (lot 2) bids: 4 (lot 2) bids: 4 (lot 2) electronicBids: 4 (lot 2) electronicBids: 4 (lot 2) electronicBids: 4 (lot 2) electronicBids: 4 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) foreignBidsFromNonEU: 0 (lot 2) smeBids: 2 (lot 2) smeBids: 2 (lot 2) smeBids: 2 (lot 2) smeBids: 2 (lot 2) bids: 4 (lot 3) bids: 4 (lot 3) bids: 4 (lot 3) bids: 4 (lot 3) electronicBids: 4 (lot 3) electronicBids: 4 (lot 3) electronicBids: 4 (lot 3) electronicBids: 4 (lot 3) foreignBidsFromEU: 0 (lot 3) foreignBidsFromEU: 0 (lot 3) |
Buyer and organisations in this procedure
The NHS Commissioning Board (operating under the name of NHS England)
Contracting authority GB-FTS-2505Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published